B

Berclaz, Luc M.; Di Gioia, Dorit; Jurinovic, Vindi; Völkl, Michael; Güler, Sinan E.; Albertsmeier, Markus; Klein, Alexander; Dürr, Hans Roland; Mansoorian, Sina; Knösel, Thomas; Kunz, Wolfgang G.; von Bergwelt-Baildon, Michael; Lindner, Lars H.; Burkhard-Meier, Anton (2025): LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment. BMC Cancer, 25: 496. ISSN 1471-2407

Berclaz, Luc M.; Di Gioia, Dorit; Völkl, Michael; Jurinovic, Vindi; Klein, Alexander; Dürr, Hans Roland; Knösel, Thomas; Teodorescu, Bianca; Enßle, Stefan; Rippl, Michaela; Bergwelt-Baildon, Michael von; Kunz, Wolfgang G.; Lindner, Lars H.; Burkhard-Meier, Anton (2025): The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma. BMC Cancer, 25: 671. ISSN 1471-2407

F

Fromm, Julian; Klein, Alexander; Kirilova, Maya; Lindner, Lars Hartwin; Nachbichler, Silke; Holzapfel, Boris Michael; Goller, Sophia Samira; Knösel, Thomas; Dürr, Hans Roland (2024): The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma– does it influence prognosis? BMC Cancer, 24 (1). ISSN 1471-2407

G

Guggenberger, J.; Kenndoff, S.; Taugner, J.; Käsmann, Lukas ORCID: 0000-0002-4372-3597; Flörsch, B.; Belka, C.; Eze, C.; Manapov, F. (2022): Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab. BMC Cancer, 22: 317. ISSN 1471-2407

K

Käsmann, Lukas; Nieto, Alexander; Rennollet, Robert; Gurtner, Ralph; Oliinyk, Dmytro; Augustin, Teresa; Koehler, Viktoria Florentine; Neu, Maria; Belka, Claus; Spitzweg, Christine; Rauch, Josefine (2024): Validation of two predictive models for survival in anaplastic thyroid cancer (ATC). BMC Cancer, 24: 1477. ISSN 1471-2407

M

Manger, Isabel; Schmitt, Christina; Berking, Carola; French, Lars E.; Vera-Gonzalez, Julio; Heinzerling, Lucie (2025): Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study. BMC Cancer, 25: 565. ISSN 1471-2407